Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease
- PMID: 24838304
- DOI: 10.1177/0284185114534652
Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease
Abstract
Background: With the advent of 3-T magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI), many subcentimeter hepatic nodules have been frequently detected in patients with chronic liver disease, and the prediction of subcentimeter nodules that progress to hypervascular hepatocellular carcinoma (HCC) is important.
Purpose: To reveal the imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR images in patients with chronic liver disease that may be related with progression to hypervascular HCC.
Material and methods: This study included 109 patients with 135 subcentimeter hypointense nodules (103 hepatocellular carcinomas [HCCs] and 32 benign nodules) on gadoxetic acid-enhanced hepatobiliary phase. For each subcentimeter nodule, the following imaging features were analyzed: (i) hyperintensity on T2-weighted (T2W) image or DWI; (ii) arterial hypervascularization; and (iii) hypointensity on a portal or late phase. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of those imaging features for predicting subcentimeter nodules that progressed to hypervascular HCC were evaluated. Volume doubling time (VDT) of subcentimeter nodules that progressed to hypervascular HCC was compared to that of growing benign nodules.
Results: Arterial hypervascularization with washout yielded the highest specificity (90.6%) and PPV (95.4%) for prediction of subcentimeter nodules that progressed to hypervascular HCC. Combining hyperintensity on T2W image or DWI and arterial hypervascularization with washout did not raise the specificity (90.6%) for prediction of subcentimeter nodules that progressed to hypervascular HCC. Mean VDT (112.2 ± 106.3 days) of subcentimeter nodules that progressed to hypervascular HCC during follow-up was significantly shorter than those of benign subcentimeter nodules (1258 ± 766.5 days, P < 0.001).
Conclusion: Arterial hypervascularization with washout in subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver disease is strongly related with progression to hypervascular HCC.
Keywords: MRI; diffusion-weighted imaging; hepatocellular carcinoma; liver.
© The Foundation Acta Radiologica 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Similar articles
-
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237. AJR Am J Roentgenol. 2011. PMID: 22021534
-
Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.Radiology. 2012 Oct;265(1):104-14. doi: 10.1148/radiol.12112649. Epub 2012 Aug 13. Radiology. 2012. PMID: 22891358
-
Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.AJR Am J Roentgenol. 2011 Jun;196(6):W758-65. doi: 10.2214/AJR.10.4394. AJR Am J Roentgenol. 2011. PMID: 21606265
-
Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.Dig Dis. 2014;32(6):696-704. doi: 10.1159/000368002. Epub 2014 Oct 29. Dig Dis. 2014. PMID: 25376286 Review.
-
Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.J Magn Reson Imaging. 2015 Feb;41(2):251-65. doi: 10.1002/jmri.24712. Epub 2014 Aug 8. J Magn Reson Imaging. 2015. PMID: 25104398 Review.
Cited by
-
Breakthrough Imaging in Hepatocellular Carcinoma.Liver Cancer. 2016 Feb;5(1):47-54. doi: 10.1159/000367761. Epub 2015 Dec 18. Liver Cancer. 2016. PMID: 26989659 Free PMC article. No abstract available.
-
Diagnostic Values of the Liver Imaging Reporting and Data System in the Detection and Characterization of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Cureus. 2023 Mar 13;15(3):e36082. doi: 10.7759/cureus.36082. eCollection 2023 Mar. Cureus. 2023. PMID: 37065286 Free PMC article. Review.
-
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan.Liver Cancer. 2015 Mar;4(1):39-50. doi: 10.1159/000367727. Liver Cancer. 2015. PMID: 26020028 Free PMC article. Review.
-
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.Gut Liver. 2019 May 15;13(3):227-299. doi: 10.5009/gnl19024. Gut Liver. 2019. PMID: 31060120 Free PMC article.
-
Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.Eur Radiol. 2024 Apr;34(4):2271-2282. doi: 10.1007/s00330-023-10214-0. Epub 2023 Oct 4. Eur Radiol. 2024. PMID: 37792079
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical